Edwards Lifesciences Corp Market Cap ($51.66 Billion)
Market Cap & Net Worth: Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp market cap. Edwards Lifesciences Corp (NYSE:EW) has a market capitalization of $51.66 Billion ($51.66 Billion) as of October 31, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #527 globally and #263 in its home market, demonstrating a 2.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Edwards Lifesciences Corp's stock price $92.01 by its total outstanding shares 575800000 (575.80 Million).
Edwards Lifesciences Corp Market Cap History (2015–2026)
Edwards Lifesciences Corp market cap history from 2015 to 2026. Data shows growth from $15.16 Billion to $52.98 Billion (12.43% CAGR). Check current stock price of Edwards Lifesciences Corp for real-time trading data and today's change.
Index Memberships
Edwards Lifesciences Corp is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$61.47 Trillion | 0.09% | #208 of 503 |
Weight: Edwards Lifesciences Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Edwards Lifesciences Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Edwards Lifesciences Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Edwards Lifesciences Corp operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
8.09x
Edwards Lifesciences Corp's market cap is 8.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
45.73x
Edwards Lifesciences Corp's market cap is 45.73 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $17.98 Billion | $2.96 Billion | $569.50 Million | 6.07x | 31.58x |
| 2017 | $21.63 Billion | $3.44 Billion | $622.10 Million | 6.30x | 34.77x |
| 2018 | $29.40 Billion | $3.72 Billion | $722.20 Million | 7.90x | 40.71x |
| 2019 | $44.78 Billion | $4.35 Billion | $1.05 Billion | 10.30x | 42.77x |
| 2020 | $52.53 Billion | $4.39 Billion | $823.40 Million | 11.98x | 63.80x |
| 2021 | $74.59 Billion | $5.23 Billion | $1.50 Billion | 14.26x | 49.63x |
| 2022 | $42.96 Billion | $5.38 Billion | $1.52 Billion | 7.98x | 28.23x |
| 2023 | $43.90 Billion | $6.00 Billion | $1.40 Billion | 7.31x | 31.31x |
| 2024 | $42.63 Billion | $5.44 Billion | $4.17 Billion | 7.84x | 10.21x |
| 2025 | $49.09 Billion | $6.07 Billion | $1.07 Billion | 8.09x | 45.73x |
Competitor Companies of EW by Market Capitalization
Companies near Edwards Lifesciences Corp in the global market cap rankings as of October 31, 2026. See Edwards Lifesciences Corp (EW) balance sheet quality index to understand what proportion of total assets are financed by equity.
Key companies related to Edwards Lifesciences Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Edwards Lifesciences Corp (2015–2026)
Market capitalization of Edwards Lifesciences Corp from 2015 to today. Between 2015 and today, Edwards Lifesciences Corp's market cap moved from $15.16 Billion to $ 52.98 Billion, with a yearly change of 12.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $52.98 Billion | +7.93% |
| 2025 | $49.09 Billion | +15.16% |
| 2024 | $42.63 Billion | -2.91% |
| 2023 | $43.90 Billion | +2.20% |
| 2022 | $42.96 Billion | -42.41% |
| 2021 | $74.59 Billion | +42.00% |
| 2020 | $52.53 Billion | +17.32% |
| 2019 | $44.78 Billion | +52.31% |
| 2018 | $29.40 Billion | +35.90% |
| 2017 | $21.63 Billion | +20.29% |
| 2016 | $17.98 Billion | +18.64% |
| 2015 | $15.16 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Edwards Lifesciences Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $51.66 Billion USD |
| MoneyControl | $51.66 Billion USD |
| MarketWatch | $51.66 Billion USD |
| marketcap.company | $51.66 Billion USD |
| Reuters | $51.66 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Edwards Lifesciences Corp
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to t… Read more